Alnylam Pharmaceuticals to Webcast Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Opportunities Conference on Thursday, July 12, 2007, at 1:30 p.m. ET at the Mandarin Oriental Hotel in New York.

MORE ON THIS TOPIC